Press Release: Corium : Corium To Present at Academy of Managed Care Pharmacy: Fast-Acting AZSTARYS (serdexmethylphenidate and dexmethylphenidate) Significantly Improves Attention and Behavior in Children Aged 6 to 12 Years With ADHD
/PRNewswire/ -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS)...
Read full article »
Corium is a Michigan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of central nervous system disorders.
Read more